Hims & Hers Health (HIMS) Share-based Compensation (2020 - 2026)

Hims & Hers Health (HIMS) reported Share-based Compensation of $39.2 million for Q1 2026, up 52.49% on a YoY basis from $25.7 million in Q1 2025, and down 2.69% sequentially from $40.3 million in Q4 2025.

Hims & Hers Health (HIMS) Share-based Compensation (2020 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 7 years of Share-based Compensation data on file, last reported at $39.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 52.49% year-over-year to $39.2 million; the trailing twelve-month figure through Mar 2026 stood at $148.7 million (up 151.33% YoY), and the FY2025 full-year result was $135.2 million, up 157.6% from the prior year.
  • Share-based Compensation fell to $39.2 million in Q1 2026, from $40.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $40.3 million in Q4 2025 to a low of -$30.4 million in Q3 2023.
  • A 5-year average of $14.7 million and a median of $19.1 million in 2022 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation tumbled 377.08% in 2023 and jumped 973.35% in 2025, its largest moves.
  • Tracing HIMS's Share-based Compensation over 5 years: stood at -$29.3 million in 2022, then surged by 119.41% to $5.7 million in 2023, then surged by 241.7% to $19.4 million in 2024, then surged by 107.62% to $40.3 million in 2025, then dropped by 2.69% to $39.2 million in 2026.
  • Business Quant data shows HIMS's Share-based Compensation at $39.2 million in Q1 2026, $40.3 million in Q4 2025, and $34.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 58.30 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 21.00 Mn
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn 39.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.21 Mn
Mar 31, 2026 39.21 Mn
Dec 31, 2025 40.29 Mn
Dec 31, 2025 40.29 Mn
Sep 30, 2025 34.37 Mn
Sep 30, 2025 34.37 Mn
Jun 30, 2025 34.87 Mn
Jun 30, 2025 34.87 Mn
Mar 31, 2025 25.71 Mn
Mar 31, 2025 25.71 Mn
Dec 31, 2024 19.41 Mn
Dec 31, 2024 19.41 Mn
Sep 30, 2024 10.82 Mn
Sep 30, 2024 10.82 Mn
Jun 30, 2024 3.25 Mn
Jun 30, 2024 3.25 Mn
Mar 31, 2024 19.03 Mn
Mar 31, 2024 19.03 Mn
Dec 31, 2023 5.68 Mn
Dec 31, 2023 5.68 Mn